Hemangioma, Cavernous, Central Nervous System
Hemangioma, Cavernous, Central Nervous System
Explore linked clinical trials. Standard reference: MESH:M03283264 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Biomarkers of CASH | Cardiovascular Abnormalities, Cavernous Sinus Syndromes, Central Nervous System Vascular Malformations, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemangioma, Cavernous, Central Nervous System, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, brain disorder, cardiovascular disorder, cavernous hemangioma, central nervous system disorder, central nervous system malformation, hemangioma, hematologic disorder, hemorrhagic disease, neoplasm, nervous system disorder, vascular cancer, vascular disorder, vascular hemostatic disease, vascular malformation | Active, not recruiting | Not stated | 2025-08-11 | NCT04467489 | |
| Study on Treatment Decision-Making and Prognostic Follow-Up for Untreated Cerebral Cavernous Malformations | Cardiovascular Abnormalities, Cavernous Sinus Syndromes, Central Nervous System Vascular Malformations, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemangioma, Cavernous, Central Nervous System, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, brain disorder, cardiovascular disorder, cavernous hemangioma, central nervous system disorder, central nervous system malformation, hemangioma, hematologic disorder, hemorrhagic disease, neoplasm, nervous system disorder, vascular cancer, vascular disorder, vascular hemostatic disease, vascular malformation | Recruiting | Not stated | 2025-07-30 | NCT06214767 | |
| Daratumumab for Familial Cerebral Cavernous Malformations: A Single-Arm Safety and Efficacy Study | Cardiovascular Abnormalities, Cavernous Hemangioma of Brain, Cavernous Sinus Syndromes, Central Nervous System Vascular Malformations, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemangioma, Cavernous, Central Nervous System, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, brain disorder, cardiovascular disorder, cavernous hemangioma, central nervous system disorder, central nervous system malformation, hemangioma, hematologic disorder, hemorrhagic disease, neoplasm, nervous system disorder, vascular cancer, vascular disorder, vascular hemostatic disease, vascular malformation | Not yet recruiting | Early phase 1 | 2025-06-18 | NCT07026604 | |
| Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy | Cardiovascular Abnormalities, Cavernous Hemangioma of Brain, Cavernous Sinus Syndromes, Central Nervous System Vascular Malformations, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Epileptic Seizures, Hemangioma, Cavernous, Central Nervous System, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, brain disorder, cardiovascular disorder, cavernous hemangioma, central nervous system disorder, central nervous system malformation, epilepsy, hemangioma, hematologic disorder, hemorrhagic disease, neoplasm, nervous system disorder, vascular cancer, vascular disorder, vascular hemostatic disease, vascular malformation, visual epilepsy | Recruiting | Not stated | 2019-09-04 | NCT04076449 |